O índice de área hiperbárica (IAH), uma nova metodologia de análise da MAPA, foi relacionado a alterações cardíacas, em especial o índice de massa ventricular esquerda (IMVE). Utilizou-se método baseado em limites pressóricos pré-definidos para os períodos de vigília e sono, considerando-se a área excedente a tais limites durante o exame como o índice hiperbárico. Observou-se relação linear direta e significativa entre IAH e IMVE. Observou-se também maior participação dos IAH de sono, sistólicos e diastólico, em determinar alterações de IMVE / The hyperbaric index area (HIA), a new methodology for ABPM analysis, was tested for its relationship to cardiac alterations, particularly with left ventricular mass index (LVMI). Calculation was based on pre-defined pressure limits for ABPM periods of sleep and activity, considering the exceeding area during the time of exam as the hyperbaric index. It was observed a statistically significant linear relation between HIA and LVMI. It was also observed a greater relation for the sleep HIA, both systolic and diastolic with changes in LVMI

Introdução: A insuficiência cardíaca é uma síndrome clínica, complexa e progressiva, que pode resultar de qualquer distúrbio funcional ou estrutural do coração que altere sua capacidade de enchimento e/ou ejeção, sendo que a maior parte dos pacientes evolui com disfunção ventricular esquerda (DVE). O exercício físico é aceito como um importante coadjuvante no tratamento desta condição clínica por promover significativa melhora da capacidade funcional dos pacientes, entretanto os mecanismos pelos quais isto ocorre ainda não estão totalmente elucidados. Neste contexto, a Ecocardiografia com Perfusão Miocárdica em Tempo Real (EPMTR) pode ser um método bastante útil tanto na avaliação de parâmetros hemodinâmicos quanto de perfusão miocárdica, facilitando o melhor entendimento das alterações fisiopatológicas promovidas pela reabilitação cardiovascular por exercício físico supervisionado (RCVEFS) e conseqüentemente, seu impacto terapêutico no prognóstico deste grave grupo de pacientes. Objetivo: Avaliar se a RCVEFS pode melhorar a reserva de fluxo miocárdico, medida pela ecocardiografia com perfusão miocárdica em tempo real, em pacientes com DVE de etiologia não isquêmica. Métodos: Avaliamos prospectivamente 40 pacientes maiores de 18 anos, com disfunção ventricular esquerda definida por fração de ejeção do ventrículo esquerdo (FEVE) calculada pelo método de Simpson <45% e sem limitações para a prática de exercício físico, que foram convidados para um programa de RCVES por um período de 4 meses. Os pacientes foram randomizados para Grupo Treinamento ou Grupo Controle. Foram realizados, na sua entrada no estudo e após 04 meses de acompanhamento dos grupos, ergoespirometria e EPMTR. A análise da perfusão foi realizada por um examinador independente (cego), que verificou o pico de intensidade miocárdica normalizado pela intensidade acústica da cavidade (An), velocidade de repreenchimento das microbolhas após sua destruição completa com um feixe de alta energia ultrassônica (ß) e o fluxo sanguíneo miocárdico (An x ß), utilizando o programa Q-Lab Philips Ultrasson. Resultados: Dos 40 pacientes inicialmente selecionados, 23 concluíram o estudo, sendo 13 no Grupo Treinamento (idade média 53 ± 13 anos, sendo 09 do sexo masculino, 15% tabagistas, 38% dislipidemia, 85% Hipertensão Arterial Sistêmica (HAS), 15% Diabetes Melito (DM) e 31% Doença de Chagas) e 10 no Grupo Controle (idade média 59 ± 12 anos, sendo 04 do sexo masculino, 10% tabagistas, 50% dislipidemia, 90% HAS, 30% DM e 10% Doença de Chagas). Não houve melhora da FEVE no Grupo Treinamento (26+14 para 26+13) e no Grupo Controle (26+6 para 27+6). No Grupo Treinamento houve aumento do An de 1,21 para 1,43 (p=0,02), do ß de 1,51 para 2,20 (p= ,0001) e do An x ß de 1,81 para 3,05 (p= 0,001); também houve melhora do VO2 Pico de 21,75ml/Kg/min para 24,76 ml/Kg/min (p= 0,0005). No Grupo Controle houve aumento do An de 1,14 para 1,15 (p=0,91), diminuição do ß de 1,72 para 1,46 (p= 0,03) e diminuição do An x ß de 1,89 para 1,55 (p= 0,01); também houve piora do VO2 Pico de 21,14 ml/Kg/min para 20,7 ml/Kg/min (p= 0,58). Conclusão: O programa de reabilitação cardiovascular por treinamento físico supervisionado melhorou a reserva de fluxo miocárdico em pacientes com Disfunção Ventricular Esquerda de etiologia não isquêmica. / Introduction: Heart failure is a clinical, complex and progressive syndrome, which may result from any structural or functional heart disorder that changes its capacity of filling and/or ejection, and the majority of patients perform evolution with left ventricular dysfunction (DVE). The exercise training is accepted as an important adjuvant in the treatment of this clinical condition by promoting significant improvement in patients functional capacity; however the mechanisms by which this occurs are still not fully elucidated. In this context, Echocardiography with Real Time Myocardial Perfusion (EPMTR) can be a very useful method as much the evaluation of hemodynamic parameters as myocardial perfusion, facilitating a better understanding of the physiopathologic changes promoted by the cardiovascular rehabilitation by supervised exercise training (RCVEFS) and consequently, its therapeutic impact on the prognosis of this critical group of patients. Objective: Evaluate if the RCVEFS can improve the myocardial flow reserve, measured by echocardiography with real time myocardial perfusion, in patients with non-ischemic etiology DVE. Methods: We prospectively evaluated 40 patients over 18 years old with left ventricular dysfunction defined by ejection fraction of left ventricle (LVEF) calculated by Simpson Method <45% and without limitations of physical exercise practice, that were invited to a RCVES program in a period of 4 months. Patients were randomly assigned to a training group or control group. There were performed in their study beginning and after 04 months of group attendance, ergo spirometry and EPMTR. The perfusion analysis was performed by an independent examiner (blind), that verified the myocardial peak intensity regularized by the acoustic cavity intensity (An), micro bubbles refilling speed after their complete destruction with a high ultrasonic energy beam (ß) and myocardial blood flow (An x ß), using Q-Lab Philips Ultrasound Program. Results: From 40 patients initially selected, 23 concluded the study, being 13 in training group (average age 53 ± 13 years, 09 male, 15% smokers, 38% Dyslipedemia, 85% high blood pressure (HBP), 15 % mellitus diabetes (DM) and 31% Chagas disease) and 10 in the control group (mean age 59 ± 12 years, 04 male, 10% smokers, 50% dyslipidemia, hypertension 90%, 30% and 10% DM Chagas disease). There was no LVEF improvement in the group training (26 + 14 to 26 + 13) and the control group (26 + 6 to 27 + 6). In the training group there was An increase of 1.21 to 1.43 (p = 0.02) of ß from 1.51 to 2.20 (p = 0.0001) and An x ß of 1.81 to 3.05 (p = 0001), there was also VO2 peak improvement of 21.75 ml / kg / min to 24.76 ml / kg / min (p = 0, 0005). In the control group there was An increase of 1.14 to 1.15 (p = 0.91), ß decrease from 1.72 to 1.46 (p = 0.03) and reduction in An x ß of 1.89 to 1.55 (p = 0.01), there was also VO2 peak deterioration 21.14 ml/kg/min to 20.7 ml/kg/min (p =0.58). Conclusion: The Cardiovascular Rehabilitation Program by Supervised Physical Training improved the myocardial flow reserve, in patients with Left Ventricular Dysfunction of non-ischemic etiology.

Introdução: A doença valvar aórtica grave é caracterizada por um processo de acúmulo progressivo de fibrose intersticial no tecido miocárdico. No contexto da sobrecarga mecânica crônica do VE característica dessa condição, a quantidade de fibrose intersticial pode exercer um papel importante na indesejável transição entre hipertrofia ventricular esquerda compensada e insuficiência cardíaca congestiva clinicamente manifesta. Entretanto, a avaliação quantitativa da fibrose intersticial só tem sido possível através da análise histopatológica de fragmentos miocárdicos obtidos por biopsia endomiocárdica. Objetivos: Avaliar se a ressonância magnética (RM) cardíaca com técnica do realce tardio permite a quantificação não-invasiva da fibrose miocárdica quando comparada à análise histopatológica em pacientes portadores de doença valvar aórtica grave. Adicionalmente, avaliou-se a relação entre a quantidade de fibrose miocárdica e parâmetros prognósticos importantes, tais como mortalidade e recuperação funcional do VE após cirurgia de troca valvar aórtica. Métodos: Entre Maio de 2001 e Dezembro de 2003 foram incluídos 54 pacientes com indicação de cirurgia de troca valvar aórtica. Antes da cirurgia, todos os pacientes foram submetidos a RM cardíaca com técnicas de cine-RM e realce tardio miocárdico. A quantificação da fibrose miocárdica pela RM baseou-se na análise das imagens de realce tardio utilizando um novo algoritmo semi-automático. As regiões de fibrose miocárdica foram definidas como o somatório de todos os pixels do tecido miocárdico com intensidade de sinal acima de um limiar definido como: intensidade de sinal média do miocárdio + 2 desvios padrão da intensidade de sinal média da área remota + 2 desvios padrão da intensidade de sinal média do ar. Amostras de tecido miocárdico obtidas por miectomia durante o ato cirúrgico foram submetidas a coloração pelo picrosírius para quantificação da fibrose intersticial. Os pacientes foram submetidos a um segundo exame de RM cardíaca 6 meses após a cirurgia para se avaliar as alterações evolutivas dos parâmetros funcionais do VE e todos foram acompanhados por pelo menos 24 meses quanto à sobrevida após a cirurgia de troca valvar aórtica. Resultados: O percentual de fibrose miocárdica pela RM apresentou boa correlação com os valores obtidos pela histopatologia (r=0,69; y=3,10x+13,0; p<0,0001). A quantidade de fibrose miocárdica, tanto pela histopatologia como pela RM, apresentou correlação inversa significativa com a FE ventricular esquerda basal (r=-0,63 e -0,67 respectivamente; p<0,0001). Adicionalmente, o percentual de fibrose miocárdica apresentou correlação inversa significativa com o grau de recuperação funcional do VE após a cirurgia de troca valvar (r=- 0,42, p=0,04 para a histopatologia; r=-0,47, p=0,02 para a RM). Mais importante, a análise de Kaplan-Meier revelou que o acúmulo de fibrose miocárdica associou-se a menor sobrevida 52±17 meses após a cirurgia de troca valvar (teste log-rank: 2=6,32; p=0,01 para histopatologia; 2=5,85; p=0,02 para RM). Conclusões: A RM cardíaca permite quantificar as regiões de fibrose miocárdica com boa acurácia quando comparada à análise histopatológica nos pacientes portadores de doença valvar aórtica grave. A magnitude de acúmulo de fibrose miocárdica está associada a pior recuperação funcional do VE e a menor sobrevida após a cirurgia de troca valvar aórtica. / Introduction: Severe aortic valve disease is characterized by a process of progressive accumulation of interstitial fibrosis in the myocardial tissue. It has been shown that the amount of interstitial myocardial fibrosis can play an important role in the transition from well-compensated hypertrophy to overt heart failure in the setting of chronic left ventricular mechanical overload typical of this condition. However, assessment of interstitial myocardial fibrosis has only been possible through histological analyses of myocardial fragments obtained from endomyocardial biopsies, which is a complex and invasive procedure and, therefore, with limited clinical applicability. Objectives: Determine whether delayedenhancement cardiac magnetic resonance imaging (MRI) allows for the non-invasive quantification of myocardial fibrosis when compared against histopathological analyses in patients with severe aortic valve disease. Additionally, we evaluated the relationship between the amount of myocardial fibrosis and important prognostic parameters, such as all-cause mortality and LV functional recovery after aortic valve replacement. Methods: Fifty-four patients scheduled to undergo aortic valve replacement surgery were enrolled between May 2001 and December 2003. Before surgery, all patients underwent cine and delayedenhancement MRI in a 1.5 Tesla scanner. Quantification of myocardial fibrosis by cardiac MRI was based on the assessment of the delayed-enhancement dataset using a novel semiautomatic algorithm. The regions of myocardial fibrosis were defined as the sum of pixels with signal intensity above a threshold value defined as: mean signal intensity of the myocardium + 2 standard deviations of mean signal intensity of a remote area + 2 standard deviations of mean signal intensity of air. During open-heart surgery, myectomy samples were acquired from the LV septum and later stained with picrosirius for interstitial myocardial fibrosis quantification. A second cardiac MRI study was performed 6 months after surgery to assess long-term changes in LV functional parameters, and all patients were followed for at least 24 months to evaluate survival after aortic valve replacement. Results: There was a good correlation between the values of myocardial fibrosis measured by MRI and those obtained by histopathological analyses (r=0.69; y=3.10x+13.0; p<0.0001). The amount of myocardial fibrosis, either by MRI or by histopathology, exhibited a significant inverse correlation with LV ejection fraction before surgery (r=-0.63 e -0.67 respectively; p<0.0001). Additionally, the amount of myocardial fibrosis displayed a significant inverse correlation with the degree of LV functional recovery after aortic valve replacement (r=-0.42, p=0.04 for histopathology; r=-0.47, p=0.02 for MRI). Most importantly, Kaplan-Meier and Cox regression analyses revealed that higher degrees of myocardial fibrosis accumulation were associated with worse survival 52±17 months after aortic valve replacement surgery (log-rank test: 2=6.32; p=0.01 for histopathology; 2=5.85; p=0.02 for MRI). Conclusions: Cardiac MRI allows for the non-invasive quantification of myocardial fibrosis with good accuracy when compared with histopathological analyses in patients with severe aortic valve disease. The degree of myocardial fibrosis accumulation is associated with impaired LV functional recovery and worse survival after aortic valve replacement surgery.

<p>Anemia is common in patients with chronic kidney disease (CDK), contributes to reduced Quality of Life (QoL) and is associated with cardiovascular disease, morbidity and mortality. Epoetin raises hemoglobin (Hb) and increases QoL and physical exercise capacity. Because of concerns about safety and economics, current anemia treatment with epoetin aims to achieve subnormal Hb (110-120 g/l). Normalization of Hb may be of additional benefit regarding QoL and cardiovascular effects. The present study examines the effects of Hb normalization with epoetin on safety variables, QoL, graft function after kidney transplantation, dialysis adequacy, hemorheology, hemodynamics and cardiac autonomic function in CKD patients. </p><p>In a randomized, multicenter study comprising 416 pre-dialysis and dialysis patients no difference was observed between patients treated to a normal or a subnormal Hb level on mortality, thrombovascular events, serious adverse events, vascular access thrombosis and residual renal function. QoL was enhanced in a subgroup of hemodialysis patients. Pretransplant epoetin treatment directed toward normal Hb levels did not result in worse graft function during 6 postoperative months. Dialysis adequacy was reduced in a subgroup of hemodialysis patients after normalization of Hb. The blood flow properties of pre-dialysis patients were altered. The hemorheological investigation demonstrated that Hb normalization caused a parallel increase in hematocrit and blood viscosity without other hemorheological changes. While the total peripheral resistance index increased, the cardiac index (CI) decreased. In a separate study cardiac autonomic function, measured by heart rate variability, was decreased in pre-dialysis patients. It was improved, but not fully normalized, by Hb normalization. </p><p>On the basis of this study, Hb normalization with epoetin appears to be safe and increases QoL in hemodialysis patients though may result in lower dialysis adequacy and increased blood pressure. A reduction in CI and improved cardiac autonomic function indicate a positive effect on cardiovascular function.</p>

Background: The ageing process not only increases the risk of coronary artery disease (CAD) but also complicates its diagnosis and treatment. It is therefore important to understand the newer concepts of cardiovascular ageing physiology as well as methods of predicting the outcomes of therapeutic options available for the elderly with severe CAD. Studies of atrioventricular (AV) ring or plane motion have attracted considerable interest in the last few years as a means of assessing ventricular and atrial function. As the displacement of AV rings towards the ventricular apex is a direct reflection of longitudinal fibre contraction, its measurement by echocardiography provides additional information regarding global and regional systolic and diastolic function. Left ventricular (LV) long axis amplitude of motion, referred to as mitral valve annular (MA) motion, is reduced in CAD and to some extent in the elderly as part of the normal ageing process. Objectives &amp; Methods: The aim of the present study was two-fold. First, to investigate the relationship between the timing of MA motion and transmitral and pulmonary venous flow in healthy subjects, and to define the physiological significance of that relationship including its potential diagnostic utility. Second, to investigate the relationship between the clinical outcome and the behaviour of long axis function in patients with severe ischaemic LV dysfunction (SLVD) after percutaneous coronary angioplasty (PTCA). Transmitral early (E) and late (A) filling, and pulmonary venous flow reversal (Ar) were studied by Doppler echocardiography, while at the left lateral AV ring, the MA motion in early (Em) and late (Am) diastole were recorded by Doppler tissue imaging (DTI) and M-mode echocardiography. Results: Healthy subjects – In early diastole the onsets of LV filling (E) and relaxation (Em) were simultaneous, and peak Em preceded peak E by 26 msec in all age groups, constituting a time interval referred to as early diastolic temporal discordance (EDTD). Similarly, the onsets of Am, A and Ar were simultaneous at onset and began approximately 84 msec after the electrocardiographic P wave. Peak Am preceded peak A by 23 msec in the young and by 13 msec in the elderly, a time interval referred to as late diastolic temporal discordance (LDTD). Peak Ar, on the other hand, coincided with peak Am in all age groups. With increasing age and sequential prolongation of isovolumic relaxation time, the peaks of Am, Ar and A converged. This point of convergence is described as atrial mechanical alignment (AMA). Patients – MA total amplitude of motion, rates of shortening and lengthening were all reduced in patients with SLVD. At mid-term, 3-6 months after PTCA, there was improvement in all these variables. A pre-procedure long axis cut off value of ≥5 mm was associated with favourable symptomatic outcome. Overall angiographic success was 95.2%, and event-free survival was 78.4% at one month and declined steadily to 62.3% at one year with 2.5% mortality. Conclusions: EDTD, which reflects ventricular restoring forces (suction) is age independent while the narrowing of LDTD leading to AMA provides a novel method to identify healthy subjects at increased dependency on left atrial contraction for late diastolic filling. Peak atrial contraction (Am) coincides with peak Ar, thus the timing of regional atrial contraction by DTI can be used to estimate corresponding measurements of Ar, which is often difficult to image by transthoracic echocardiography. In patients with SLVD long axis total amplitude of at least 5 mm at the left MA suggests a significant potential for segmental function recovery after PTCA. Keywords: Echocardiography, Doppler tissue imaging, ageing, coronary disease, left ventricular dysfunction, atrial contraction, electromechanical function, coronary angioplasty.

Anemia is common in patients with chronic kidney disease (CDK), contributes to reduced Quality of Life (QoL) and is associated with cardiovascular disease, morbidity and mortality. Epoetin raises hemoglobin (Hb) and increases QoL and physical exercise capacity. Because of concerns about safety and economics, current anemia treatment with epoetin aims to achieve subnormal Hb (110-120 g/l). Normalization of Hb may be of additional benefit regarding QoL and cardiovascular effects. The present study examines the effects of Hb normalization with epoetin on safety variables, QoL, graft function after kidney transplantation, dialysis adequacy, hemorheology, hemodynamics and cardiac autonomic function in CKD patients. In a randomized, multicenter study comprising 416 pre-dialysis and dialysis patients no difference was observed between patients treated to a normal or a subnormal Hb level on mortality, thrombovascular events, serious adverse events, vascular access thrombosis and residual renal function. QoL was enhanced in a subgroup of hemodialysis patients. Pretransplant epoetin treatment directed toward normal Hb levels did not result in worse graft function during 6 postoperative months. Dialysis adequacy was reduced in a subgroup of hemodialysis patients after normalization of Hb. The blood flow properties of pre-dialysis patients were altered. The hemorheological investigation demonstrated that Hb normalization caused a parallel increase in hematocrit and blood viscosity without other hemorheological changes. While the total peripheral resistance index increased, the cardiac index (CI) decreased. In a separate study cardiac autonomic function, measured by heart rate variability, was decreased in pre-dialysis patients. It was improved, but not fully normalized, by Hb normalization. On the basis of this study, Hb normalization with epoetin appears to be safe and increases QoL in hemodialysis patients though may result in lower dialysis adequacy and increased blood pressure. A reduction in CI and improved cardiac autonomic function indicate a positive effect on cardiovascular function.

No description available.

L’hypertrophie du ventricule gauche (HVG) est un processus adaptif et compensatoire qui se développe conséquemment à l’hypertension artérielle pour s’opposer à l’élévation chronique de la pression artérielle. L’HVG est caractérisée par une hypertrophie des cardiomyocytes suite à l’augmentation de la synthèse d’ADN, une prolifération des fibroblastes, une augmentation du dépôt de collagène et une altération de la matrice extracellulaire (MEC). Ces changements génèrent des troubles de relaxation et mènent au dysfonctionnement diastolique, ce qui diminue la performance cardiaque. La suractivité du système nerveux sympathique (SNS) joue un rôle essentiel dans le développement de l’hypertension artérielle et de l’HVG à cause de la libération excessive des catécholamines et de leurs effets sur la sécrétion des cytokines pro-inflammatoires et sur les différentes voies de signalisation hypertrophiques et prolifératives. Le traitement antihypertenseur avec de la moxonidine, un composé sympatholytique d’action centrale, permet une régression de l’HVG suite à une réduction soutenue de la synthèse d'ADN et d’une stimulation transitoire de la fragmentation de l'ADN qui se produit au début du traitement. En raison de l’interaction entre l’HVG, les cytokines inflammatoires, le SNS et leurs effets sur les protéines de signalisation hypertrophiques, l’objectif de cette étude est de détecter dans un modèle animal d’hypertension artérielle et d’HVG, les différentes voies de signalisation associées à la régression de l’HVG et à la performance cardiaque. Des rats spontanément hypertendus (SHR, 12 semaines) ont reçu de la moxonidine à 0, 100 et 400 µg/kg/h, pour une période de 1 et 4 semaines, via des mini-pompes osmotiques implantées d’une façon sous-cutanée. Après 4 semaines de traitement, la performance cardiaque a été mesurée par écho-doppler. Les rats ont ensuite été euthanasiés, le sang a été recueilli pour mesurer les concentrations des cytokines plasmatiques et les cœurs ont été prélevés pour la détermination histologique du dépôt de collagène et de l'expression des protéines de signalisation dans le ventricule gauche. Le traitement de 4 semaines n’a eu aucun effet sur les paramètres systoliques mais a permis d’améliorer les paramètres diastoliques ainsi que la performance cardiaque globale. Par rapport au véhicule, la moxonidine (400 µg/kg/h) a permis d’augmenter transitoirement la concentration plasmatique de l’IL-1β après une semaine et de réduire la masse ventriculaire gauche. De même, on a observé une diminution du dépôt de collagène et des concentrations plasmatiques des cytokines IL-6 et TNF-α, ainsi qu’une diminution de la phosphorylation de p38 et d’Akt dans le ventricule gauche après 1 et 4 semaines de traitement, et cela avec une réduction de la pression artérielle et de la fréquence cardiaque. Fait intéressant, les effets anti-hypertrophiques, anti-fibrotiques et anti-inflammatoires de la moxonidine ont pu être observés avec la dose sous-hypotensive (100 µg/kg/h). Ces résultats suggèrent des effets cardiovasculaires bénéfiques de la moxonidine associés à une amélioration de la performance cardiaque, une régulation de l'inflammation en diminuant les niveaux plasmatiques des cytokines pro-inflammatoires ainsi qu’en inhibant la MAPK p38 et Akt, et nous permettent de suggérer que, outre l'inhibition du SNS, moxonidine peut agir sur des sites périphériques. / Left ventricular hypertrophy (LVH) is an adaptive and compensatory process that develops in hypertension to oppose the chronic elevation of blood pressure. LVH is characterized by hypertrophy of cardiomyocytes following the increase in DNA synthesis, proliferation of fibroblasts, increased collagen deposition and alteration of the extracellular matrix (ECM). These changes generate relaxation and diastolic dysfunction which reduced cardiac performance. The overactivity of the sympathetic nervous system plays an essential role in the development of hypertension and left ventricular hypertrophy pathogenesis due to the excessive release of catecholamines and norepinephrine spillover and their effects on the secretion of pro-inflammatory cytokines and hypertrophic signaling pathways. Antihypertensive treatment with moxonidine, a centrally acting sympatholytic imidazoline compound, results in prevention of left ventricular hypertrophy, resulting from a sustained reduction of DNA synthesis and transient stimulation of DNA fragmentation that occur early after treatment. Due to the interaction between LVH, inflammatory cytokines, the SNS and their effects on hypertrophic signaling proteins, the objective of this study is to detect in an animal model of hypertension and LVH, the different signaling pathways associated with regression of LVH and cardiac performance. Spontaneously hypertensive rats (SHR, 12 weeks old) received moxonidine at 0, 100 and 400 µg/kg/h, for 1 and 4 weeks, via subcutaneously implanted osmotic minipumps. After 4 weeks of treatment, cardiac performance was measured by echo-Doppler. Then the rats were euthanized, blood was collected for measurement of plasma cytokines and hearts for histologic determination of collagen deposition and for measurement of left ventricular expression of downstream signaling proteins. Treatment for 4 weeks had no effect on systolic parameters but improved diastolic parameters and global cardiac performance. Compared to vehicle, moxonidine (400 µg/kg/h) transiently increased plasma IL-1β after 1 week and reduced left ventricular mass. Similarly, there was a decrease in collagen deposition and plasma concentrations of IL-6 and TNF-α, and decreased phosphorylation of p38 and Akt in the left ventricle after 1 and 4 weeks treatment, in association with reduced blood pressure and heart rate. Interestingly, the anti-hypertrophic, anti-fibrotic, and anti-inflammatory effects of moxonidine were observed with a sub-hypotensive dose (100µg/kg/h). These results suggest the beneficial cardiovascular effects of moxonidine associated with improved cardiac performance, regulation of inflammation by decreasing pro-inflammatory plasma levels, inhibition of p38 MAPK and Akt, and allow us to suggest that besides inhibiting the SNS, moxonidine may act on peripheral sites.

Made available in DSpace on 2016-06-02T19:22:57Z (GMT). No. of bitstreams: 1 5061.pdf: 12379581 bytes, checksum: c5740c3bf0a93d60530d4f55769c222d (MD5) Previous issue date: 2013-03-22 / Universidade Federal de Sao Carlos / Obesity is associated with increased lipid peroxidation in the myocardium and an increased susceptibility to oxidative damage, which can lead to several cardiovascular risk factors including heart failure, insulin resistance, hypertension and dyslipidemia. The ONOOin conjunction with normal intracellular levels of reduced glutathione (GSH), are responsible, among other factors, to activate the matrix metalloproteinases (MMPs) that are important in mediating the deleterious effects of cardiovascular diseases. The unregulated activity of MMPs, such as MMP-2, may promote the development of heart disease. Resistance training (RT) can mitigate or even reverse the obesity, prevent against lipid peroxidation, increasing the levels of antioxidant enzymes, improved lipid profile, reduced cardiovascular risk and reduce the concentration of fibrosis and dysregulation of MMP-2. Purpose: To analyze the effects of RT high intensity on ladder associated with high fat diet on the activity of MMP-2 and antioxidant enzymes (SOD Total, Mn-SOD, CAT, GPx), GSH and lipid peroxidation, related to left ventricle remodeling in rats. Methods: 60 rats Wistar were used in this study, which was divided into three phases: 1) three week period of obesity induction, control group fed with standard diet (CT-S n = 30) and control group fed with high fat diet (CT-H n = 30); 2) effect of fat diet for eight weeks, sedentary standard diet group (SED-S n = 10) and high fat diet sedentary (SED-H n = 10), 3) effect of high-intensity RT on ladder for eight weeks associated with high-fat diet, RT standard diet (RT-S n = 10) and RT high-fat diet RT (RT-H n = 10). Results: The three-week obesity induction was effective in promoting the group CTH increased body mass (p <0.05), LV mass (p <0.05) and activity of MMP-2 (p <.001), TBRs (p <0.03) and decrease the citrate synthase activity (p <0.05). After eight weeks of high fat diet, the SED-H group had a higher body mass (p <0.02) compared to SED-S. The volume LV for SED-H group was higher compared to that of CT-H (p <0.001), but did not change when compared to SED-S. There was a lower activity of MMP-2 (p <0.05) in SED-S compared to CT-H. Lipid accumulation was observed (p <0.007) in the LV of SED-H group compared to CT-H. The longer life associated with high-fat diet promoted suppression in the enzymatic activity of SOD Total (p <0.01) and Mn-SOD (p <0.002) (SED-H), and increased activity of GSH (p <0.004). The RT was effective in attenuating the gain body mass in RT-H group compared to SED-H, even though higher compared to RT-S (p <0.005). In the group RT-H of MMP-2 activity was higher (p <0.03) compared to RT-S, but lower (p <0.04) compared to SED-H. The RT promoted greater citrate synthase activity (p <0.03), SOD Total (p <0.001) and Mn-SOD (p <0.03) and lower activity of GSH (p <0.01) in RT-H. There was no significant increase in TBARs level in the VE of the RT-H group. However, we observed increased lipid content (p <0.04). Conclusion: We conclude that high intensity RT, in obese rats, could be a pharmacological tool able to positively modulate the activity of MMP-2 and some antioxidant enzymes such as SOD Total, Mn-SOD and GSH. These effects are important for the maintenance of heart health, relieving the deleterious effects on obesityrelated of the left ventricle remodeling, so experiment. / A obesidade está associada com aumento da peroxidação lipídica no miocárdio e com uma maior suscetibilidade ao dano oxidativo, o que pode levar a vários fatores de risco cardiovascular incluindo insuficiência cardíaca, resistência à insulina, hipertensão e dislipidemia. O ONOO- em conjunto com níveis normais intracelular de glutationa reduzida (GSH), são responsáveis, dentre outros fatores, por ativar as metaloproteinases de matriz (MMPs), que são importantes na mediação dos efeitos deletérios de doenças cardiovasculares. A atividade desregulada das MMPs, como a MMP-2, pode favorecer o desenvolvimento de doenças cardíacas. O treinamento resistido (TR) pode amenizar ou mesmo reverter o quadro de obesidade, prevenir contra a peroxidação lipídica, aumentando os níveis das enzimas antioxidantes, melhora do perfil lipídico, diminui os riscos á doenças cardiovasculares, além de reduzir a concentração de fibrose e a desregulação da MMP-2. Objetivo: Analisar os efeitos do TR de alta intensidade em escada associado à dieta hiperlipídica na atividade da MMP-2 e enzimas antioxidantes (SOD Total, Mn-SOD, CAT, GPx), GSH e peroxidação lipídica, relacionadas ao remodelamento do ventrículo esquerdo, em ratos. Metodologia: 60 ratos Wistar foram utilizados neste estudo, sendo este divido em três fases: 1) período de três semanas de indução à obesidade, grupo controle alimentado com dieta padrão (CT-P n= 30) e controle alimentado com dieta hiperlipídica (CT-H n= 30); 2) efeito da dieta hiperlipídica por mais oito semanas, grupo sedentário dieta padrão (SED-P n= 10) e sedentário dieta hiperlipídica (SED-H n= 10); 3) efeito do TR em escada por oito semanas associado a dieta hiperlipídica, grupo TR dieta padrão (TR-P n= 10) e TR dieta hiperlipídica (TR-H n= 10). Resultados: As três semanas de indução à obesidade foi eficaz em promover aumento da massa corporal (p < 0,05), massa do VE (p < 0,05) e da atividade da MMP-2 (p < 0,001), do TBRs (p < 0,03) e de diminuir a atividade da citrato sintase (p < 0,05) no grupo CT-H. Após mais oito semanas de dieta hiperlipídica, o grupo SED-H teve a massa corporal maior (p < 0,02) comparado ao SED-P. Já a massa do VE para o grupo SED-H foi maior em comparação ao do CT-H (p < 0,001), porém não se modificou quando comparado ao SEP-P. Houve uma menor atividade da MMP-2 (p < 0,05) no grupo SED-H comparado ao CT-H. Foi observado acúmulo de lipídios totais (p < 0,007) no VE do grupo SD-H comparado ao CT-H. O maior tempo de vida associado à dieta hiperlipídica promoveu inibição da SOD Total (p < 0,01) e Mn-SOD (p < 0,002) (SED-H), e aumento da GSH (p < 0,004). O TR foi eficaz em atenuar o ganho de massa corporal no grupo TR-H comparado ao SED-H, mesmo sendo maior comparado ao TR-P (p < 0,005). No grupo TR-H a atividade da MMP-2 foi maior (p < 0,03) comparado ao TR-P, porém menor (p < 0,04) comparado ao SED-H. O TR promoveu maior atividade das enzimas citrato sintase (p < 0,03), SOD Total (p < 0,001) e Mn-SOD (p < 0,03) menor atividade da GSH (p < 0,01) no grupo TR-H. Não foi observado aumento significativo do TBARS no VE do TR-H. Contudo, foi observado aumento do conteúdo lipídico (p < 0,04). Conclusão: Concluímos que o TR de alta intensidade, em ratos obesos, pode ser uma ferramenta não farmacológica capaz de modular de forma positiva a atividade da MMP-2 e de algumas enzimas antioxidantes como a SOD Total, Mn-SOD e a GSH. Efeitos esses que são importantes para a manutenção da saúde cardíaca, amenizando os efeitos deletérios relacionados à obesidade sobre o remodelamento do ventrículo esquerdo, de forma experimental.

Plasma levels of B-type natriuretic peptide (BNP) are a strong and independent predictor of prognosis in patients with advanced heart failure (CHF). However, the importance of this biomarker has been documented only in CHF of common causes such as dilated or ischemic cardiomyopathy. We hypothesized that BNP can serve as a strong predictor of end-stage CHF in group of patients with advanced CHF due to congenital heart disease (CHD) with the right ventricle in systemic position (SRV). The second hypothesis was that BNP monitoring in patients with implanted left ventricular assist device (LVAD) Heart Mate II could detect serious complications which negatively affect prognosis. We performed a retrospective analysis in 28 consecutive patients with severe systolic dysfunction of the SRV (ejection fraction 23 ± 6%) evaluated as heart transplant (HTx) candidates between May 2007 and October 2014. During a median follow-up of 29 months (interquartile range, 9-50), 14 pts reached primary endpoints of the study (death, urgent HTx, and LVAD implantation). We have considered these events equivalent to end-stage CHF. Using ROC analysis, we identified the first measured value of BNP as the strongest predictor of prognosis with the area under the curve (AUC) of 1.00, followed by the New York Heart Association...